Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment.

Keyphrases

• Antisense 100%
• Antisense DNA 100%
• Antisense Oligonucleotides 50%
• Apoptosis 50%
• CAMP-dependent Protein Kinase 50%
• Cancer Cell Lines 50%
• Cancer Cells 50%
• Cancer Treatment 100%
• Cell Arrest 50%
• Cell Cycle Deregulation 50%
• DNA Target 100%
• Enhanced Expression 50%
• Epithelial Origin 50%
• Epithelial Tumor 50%
• Gene Expression 50%
• Gene Targeting 50%
• Growth Arrest 50%
• Holoenzyme 50%
• Leukemia Cells 50%
• Oncogenesis 50%
• Primary Tumor 50%
• Protein Kinase 100%
• Sequence Specificity 50%
• Specific Inhibition 50%
• Target Molecule 100%
• Target-based Approach 50%
• Tumor Cell Proliferation 50%
• Tumor Cell Survival 50%
• Tumor Inhibition 50%
• Tyrosine Kinase Signaling 50%

Medicine and Dentistry

• Alpha Chain 100%
• Antisense 100%
• Antisense Oligonucleotide 50%
• Cancer Cell 50%
• Cancer Cell Line 50%
• Cancer Therapy 100%
• Cancer Treatment 50%
• Carcinogenesis 50%
• Cell Cycle 50%
• Cell Survival 50%
• Complementary DNA 100%
• Cyclic AMP Dependent Protein Kinase 100%
• Gene Expression 50%
• Gene Targeting 100%
• Growth Disorder 50%
• Holoenzyme 50%
• Kinase Signaling 50%
• Leukemia Cell 50%
• Neoplasm 50%
• Primary Tumor 50%
• Programmed Cell Death 50%
• Protein Kinases 100%
• Protein Tyrosine Kinase 50%
• Targeting Protein 100%
• Tumor Cell 50%
• Tumor Progression 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Antisense Oligonucleotide 25%
• Carcinogenesis 25%
• Complementary DNA 100%
• Cyclic AMP Dependent Protein Kinase 100%
• Gene Delivery 100%
• Growth Disorder 25%
• Holoenzyme 25%
• Leukemia 25%
• Malignant Neoplasm 100%
• Neoplasm 50%
• Primary Tumor 25%
• Protein Kinases 50%
• Protein Tyrosine Kinase 25%
• Radioimmunoassay 100%
• Tumor Growth 50%